The Role of Vitamin D Supplements on Pulmonary Hypertension in Patients with Thalassemia

Phase 3

• Conditions: Condition 1: Pulmonary Hypertension. Condition 2: Thalassemia.; Primary pulmonary hypertension; Beta thalassemia

• Registration Number: IRCT20190206042644N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 March 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Parental Informed Consent
Patients with Thalassemia Major under Regular Transfusion and Regular Chelation.
Patients with Thalassemia Intermedia who do not have Regular Transfusion.

Exclusion Criteria

Parental Dissatisfaction for Participation in the Study
Congenital and Non-congenital Heart Disease
Endocrine Disease such as Diabetes, Hypoparathyroidism and Hypothyroidism

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pulmonary Hypertension. Timepoint: Measurement of Pulmonary Arterial Pressure at the Beginning of the Study (After Entering the Study and Before the Onset of the Intervention) and Repeat Measurements 6 months after Entry into the Study. Method of measurement: Echocardiography by Echocardiologist.